Drug Type asPNA |
Synonyms 16 base single stranded peptide nucleic acid oligonucleotide ¿ 7 aminoacids peptide, 16-base single-stranded peptide nucleic acid oligonucleotide linked to 7-amino acid peptide, BGA 002 + [1] |
Target |
Mechanism N-Myc inhibitors(MYCN proto-oncogene, bHLH transcription factor inhibitors), Genetic transcription inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (US), Orphan Drug (EU) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuroblastoma | Preclinical | IT | 30 Apr 2022 | |
Soft Tissue Sarcoma | Preclinical | IT | 30 Apr 2022 | |
Small Cell Lung Cancer | Preclinical | IT | - |